SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (154)5/17/1997 4:20:00 PM
From: Miljenko Zuanic   of 675
 
NI,

Thanks for reply.

I do not have ill-tempered altitude toward any poster's on SI. But when somebody post information which concern my altitude toward company where I have investment, than I analyze this information.

Even before your post, I have checked (not only for hrGGF2) for all CNSI projects patents status. Regards the GGF, there are several patents issued before first CNSI patent. Not going in to details and because my knowledge is simply limited for this issue, your information that patent ambiguity regards hrGGF2 is reason for slowing process of the hrGGF2 collaboration. I took this very seriously. Potential collaborators will analyze this issue in very details.

Not compromising source of your information can you clear is the potential patent problem(s) in:

1. Meter of composition,
2. Indication where it can be applicable,
3. Technology for the production/manufacturing,
4. Patent(s) number which can be infringement.

Thanks in advance.

mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News